China Biologic Products, Inc. (CBPO) Posts Q1 EPS of 69c

China Biologic Products, Inc. (NASDAQ: CBPO) reported Q1 EPS of $0.69, which may not compare with the analyst estimate of $0.47. Revenue for the quarter came in at $56.27 million versus the consensus estimate of $51.4 million.

For earnings history and earnings-related data on China Biologic Products, Inc. (CBPO) click here.

You May Also Be Interested In

• CAE, Inc. (CAE) Tops Q1 EPS by 2c, Beats on Revenue; Offers FY27 EPS Guidance
• M-tron Industries, Inc. (MPTI) Misses Q2 EPS by 10c
• Marchex (MCHX) Reports In-Line Q2 EPS